India to Brazil: Insulin Export Trade Route
India has recorded 16 verified shipments of Insulin exported to Brazil, representing a combined trade value of $1.8M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $110.5K USD. The leading Indian exporter is WOCKHARDT LIMITED, which accounts for 94% of total export value with 15 shipments worth $1.7M USD. On the buying side, BIOMM S/A is the largest importer in Brazil with $805.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Insulin corridor is one of India's established pharmaceutical export routes, with 16 shipments documented worth a combined $1.8M USD. The route is dominated by WOCKHARDT LIMITED, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $110.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 25.5%, placing it at rank #17 among India's top insulin export destinations globally.
On the import side, key buyers of Indian insulin in Brazil include BIOMM S/A, BIOMM S/A,, BIOMM S A NOVA LIMA CNPJ and 2 others. BIOMM S/A is the single largest importer with 10 shipments valued at $805.8K USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeMulti-modal
- Top portJNPT
Market Position
- Global rank#17
- Annual growth+25.5%
- Demand growth+23.3%
- Regulatory ease68/100
Top 10 Indian Insulin Exporters to Brazil
Showing top 10 of 2 Indian suppliers exporting Insulin to Brazil, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | WOCKHARDT LIMITED Avg $110.9K per shipment | 15 | $1.7M | 94.1% |
| 2 | WOCKHARDT LIMITED Avg $104.6K per shipment | 1 | $104.6K | 5.9% |
This table shows the top 10 of 2 Indian companies exporting insulin to Brazil, ranked by total trade value. The listed exporters are: WOCKHARDT LIMITED, WOCKHARDT LIMITED . WOCKHARDT LIMITED is the dominant supplier with 15 shipments worth $1.7M USD, giving it a 94% market share.
Top 10 Insulin Importers in Brazil
Showing top 10 of 5 known buyers in Brazil receiving Insulin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian insulin in Brazil include BIOMM S/A, BIOMM S/A,, BIOMM S A NOVA LIMA CNPJ, BIOMM S/A.,, BIOMM S/A . The largest importer is BIOMM S/A, accounting for $805.8K USD across 10 shipments — representing 46% of all insulin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIOMM S/A | 10 | $805.8K | 45.6% |
| 2 | BIOMM S/A, | 2 | $357.8K | 20.2% |
| 3 | BIOMM S A NOVA LIMA CNPJ | 2 | $253.9K | 14.4% |
| 4 | BIOMM S/A., | 1 | $246.0K | 13.9% |
| 5 | BIOMM S/A | 1 | $104.6K | 5.9% |
Top 10 Insulin Formulations Imported by Brazil
Showing top 10 of 10 product formulations shipped on the India to Brazil Insulin route, ranked by trade value
Brazil imports a wide range of insulin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — WOSULIN N 100IU 10ML VIAL WOSULIN N, 100 IU, ISOPHANE INSULIN HUMAN SUSPENSION USP (RDNA ORIGIN), 10 ML VIAL — accounts for $305.2K USD across 3 shipments. A total of 10 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | WOSULIN N 100IU 10ML VIAL WOSULIN N, 100 IU, ISOPHANE INSULIN HUMAN SUSPENSION USP (RDNA ORIGIN), 10 ML VIAL | 3 | $305.2K | 17.3% |
| 2 | WOSULIN N 100IU 10ML VIAL WOSULIN N, 100 IU, Isophane Insulin Human Suspension USP (rDNA origin), 10 ml vial | 1 | $248.0K | 14.0% |
| 3 | WINSULIN N 100IU 10ML VIAL -GREEN CARD NO.PUNE-6 DATED 28.03.2024 VALID UPTO 31.03.2029 | 1 | $246.0K | 13.9% |
| 4 | WOSULIN N 100IU 10ML VIAL WOSULIN N, 100IU, ISOPHANE INSULIN HUMAN SUSPENSION USP (RDNA ORIGIN), 10 ML VIAL,-GREEN CARD | 1 | $240.3K | 13.6% |
| 5 | WOSULIN N 100IU 10ML VIAL WOSULIN N 100IU ISOPHANE INSULIN HUMAN SUSPENSION USP (RDNA ORIGIN) 10 ML VIAL-GREEN CARDVLS | 3 | $166.6K | 9.4% |
| 6 | WOSULIN R 100IU 10ML VIAL -BRAZ UNI WOSULIN R 100IU, INSULIN HUMAN INJECTION USPRDNA ORIGIN, 10 ML VIAL,-GREEN CARD N | 1 | $148.2K | 8.4% |
| 7 | WOSULIN R 100IU 10ML VIAL WOSULIN R 100IU, INSULIN HUMAN INJECTION USP (RDNA ORIGIN), 10 ML VIAL,-GREEN CARD NO 20956 DA | 1 | $117.5K | 6.6% |
| 8 | WOSULIN N 100IU 10ML VIAL -BRAZ UNI WOSULIN N, 100 IU, ISOPHANE INSULIN HUMAN SUSPENSION USP RDNA ORIGIN, 10 ML VIAL,- | 1 | $105.6K | 6.0% |
| 9 | WOSULIN N 100IU 10ML VIAL WOSULIN N, 100 IU, Isophane Insulin Human Suspension USP (rDNA origin), 10 ml vial, | 1 | $104.6K | 5.9% |
| 10 | WOSULIN R 100IU 10ML VIAL -BRAZ UNI WOSULIN R 100IU INSULIN HUMAN INJECTION USP(RDNA ORIGIN) 10 ML VIAL-GREEN CARD NOVLS | 3 | $86.0K | 4.9% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 17% air for urgent orders.
Top Ports of Origin
JNPT handles the highest volume with 7 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's insulin exports to Brazil are driven primarily by a handful of large-scale manufacturers. WOCKHARDT LIMITED with 15 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Brazil benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — WOCKHARDT LIMITED, WOCKHARDT LIMITED — together account for 100% of total trade value on this route. The average shipment value of $110.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as wosulin n 100iu 10ml vial wosulin n, 100 iu, isophane insulin human suspension usp (rdna origin), 10 ml vial and winsulin n 100iu 10ml vial -green card no.pune-6 dated 28.03.2024 valid upto 31.03.2029, suggesting that buyers in Brazil tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, BIOMM S/A is the largest importer with 10 shipments worth $805.8K USD — representing 46% of all insulin imports from India on this route.
Route Statistics
- Trade Volume
- $1.8M
- Avg. Shipment
- $110.5K
- Suppliers
- 2
- Buyers
- 5
- Transit (Sea)
- ~17 days
- Annual Growth
- +25.5%
Reverse Direction
Brazil → India — Insulin (Import)Other Insulin Routes
Unlock the Full India to Brazil Insulin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 16 shipments on this route.
Frequently Asked Questions — India to Brazil Insulin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Insulin to Brazil?
The leading Indian exporters of Insulin to Brazil are WOCKHARDT LIMITED, WOCKHARDT LIMITED . WOCKHARDT LIMITED holds the largest market share at approximately 94% of total trade value on this route.
Q What is the total value of Insulin exports from India to Brazil?
India exports Insulin to Brazil worth approximately $1.8M USD across 16 recorded shipments. The average value per shipment is $110.5K USD.
Q Which ports does India use to ship Insulin to Brazil?
The most active port of origin is JNPT with 7 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 17% by air.
Q How long does shipping take from India to Brazil for Insulin?
The average transit time for Insulin shipments from India to Brazil is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Brazil Insulin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.5% with demand growth tracking at 23.3%. The route is ranked #17 among India's top Insulin export destinations globally.
Q How many suppliers are active on the India to Brazil Insulin route?
There are currently 2 active Indian suppliers exporting Insulin to Brazil. The market is moderately concentrated with WOCKHARDT LIMITED accounting for 94% of total shipment value.
Q Who are the main importers of Insulin from India in Brazil?
The leading importers of Indian Insulin in Brazil include BIOMM S/A, BIOMM S/A,, BIOMM S A NOVA LIMA CNPJ, BIOMM S/A.,, BIOMM S/A . BIOMM S/A is the largest buyer with 10 shipments worth $805.8K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Brazil export trade corridor identified from Indian Customs (DGFT) records for Insulin.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 5 importers in Brazil matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 16 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists